Probabilistic association learning (also referred to as probabilistic classification learning or probabilistic category learning) is a form of non-declarative learning [1] that entails the acquisition of probabilistic based, cue-outcome associations over repeated presentations without conscious awareness that is supported by trial-by-trial feedback. The probabilistic schedule of reinforcement elicits a gradual learning of associations which is analogous to habit learning. In an elegant series of experiments in human clinical samples, Knowlton et al. [2] [3] [4] demonstrated that probabilistic association learning is dependent, at least in part, on healthy striatal functioning, with patients who have compromised striatum processing (i.e. in Parkinson's and Huntington's diseases) displaying severely impaired probabilistic association learning. Functional magnetic resonance imaging (fMRI) studies in healthy adult humans have confirmed that probabilistic association learning is dependent on frontal-striatal (especially caudate nucleus) activity while the hippocampal formation is typically deactivated [5] [6] [7] . Although the striatum (e.g. caudate nucleus) is the primary site of elevated dopamine and antipsychotic medication action (which is associated with dopamine D2 receptor blockade necessary to reduce psychotic symptom severity) in schizophrenia [8] , the majority of schizophrenia research has focused on cognitive deficits that depend primarily on brain regions other than the striatum. However, the striatum is relevant to many cognitive processes [9] and thus, this review will focus on recent findings pertaining to dorsal striatum (caudate nucleus) function in schizophrenia as assessed by probabilistic association learning.
Schizophrenia is a heterogenous disorder in which symptom presentation, cognitive impairment and treatment response is variable [10, 11] . While most studies of schizophrenia focus on cortical dysfunction and declarative/ explicit cognitive processes [1, 11] , striatal dependent cognitive dysfunction is often ignored given that evidence for the role of increased dopamine levels in schizophrenia was formerly limited to indirect associations of symptom severity reduction with dopamine D2 receptor antagonism [12, 13] and that any striatal learning processes may be negatively influenced by antipsychotics in chronically ill patients. The aim of this review is to present a body of work that supports the role of the striatum, and specifically the caudate nucleus, in the pathophysiology of schizophrenia.
While some previous studies have assessed cognitive habit learning in schizophrenia [14] , the cognitive assay used has been shown to rely on working memory and declarative processes [15] . Thus, the probabilistic association learning 'weather prediction' assay provided a valid assay of striatal related cognitive habit learning deficits in schizophrenia. This was an important step, since it helped to redirect the field of schizophrenia research away from a sole focus on cortical function and declarative learning deficits toward an additional focus on subcortical, striatal dependent, cognitive dysfunction in schizophrenia.
However, in order to provide convincing support for the role of striatal dependent probabilistic association learning abnormalities in the etiology and pathophysiology of schizophrenia, the following evidence should be established: (1) the presence of the abnormality in a substantial proportion of chronically ill patients with schizophrenia, (2) evidence for abnormal neuronal activity during probabilistic association learning, (3) evidence for these abnormalities in unaffected siblings, those at high risk for the illness, healthy people displaying a high degree of schizotypal personality traits and chronically ill patients who are withdrawn from antipsychotics (all of which would support that the abnormalities are intrinsic to the illness), and (4) abnormal molecular mechanisms related to striatal dependent probabilistic association learning deficits in schizophrenia. This review will provide a brief overview of the current evidence.
Probabilistic association learning in schizophrenia
Initial work in schizophrenia suggested that probabilistic association learning was preserved in patients with schizophrenia [16] ; however, the majority of subsequent studies have identified probabilistic association learning deficits in patients with schizophrenia. Most studies have shown overall performance level differences with no acquisition (learning) rate differences between patients with schizophrenia and healthy controls during probabilistic association learning [17] [18] [19] ; thus, initially suggesting intact striatal function with impaired prefrontal cortex input to the circuit. However, some studies have shown differences in both overall performance level and learning acquisition rate between patients with schizophrenia and healthy comparison groups [20, 21] ; thus, suggesting abnormal frontal-striatal function.
Studies comparing patients with schizophrenia to other patient groups characterized by either striatal (e.g. Parkinson's disease) or frontal lobe (e.g. Frontotemporal dementia) deficits have shown that probabilistic association learning impairment in schizophrenia can have aspects of both frontal lobe and striatal dysfunction. In a comparison to age matched healthy control groups, both patients with schizophrenia and Frontotemporal dementia patients displayed impaired probabilistic association learning and these two patient groups did not differ significantly [22] . Conversely, while patients with Parkinson's disease (who have substantia nigra neuronal loss resulting in depletion of dopamine projections to the striatum) failed to improve significantly above chance levels of performance whether they were receiving or they were withdrawn from dopamimetic medication, patients with schizophrenia who were withdrawn from antipsychotic medications did not improve significantly above chance levels of performance during the early learning phase (i.e. the first 100/150 trials), suggesting striatal abnormalities contribute to probabilistic association learning impairment in schizophrenia [23 ] . These studies clearly establish probabilistic association learning deficits in chronically ill patients with schizophrenia. However, other studies were needed to identify specific abnormal neuronal activity in conjunction with these learning deficits in schizophrenia.
The neural underpinnings of probabilistic association learning in schizophrenia
An fMRI study of 40 patients with schizophrenia and 25 healthy controls has shown that, in general, patients with schizophrenia display reduced frontal-striatal activity relative to healthy controls during probabilistic association learning ( Figure 1a,b) ; however, a subset of patients with schizophrenia who attain normal learning and performance levels display increased activity in the parahippocampal gyrus, rostral prefrontal, cingulate, and parietal cortices (Figure 1c ) [24 ] . This finding presents an interesting contrast to previous elegant fMRI work in healthy adults showing that while healthy adults initially activate the hippocampus during probabilistic association learning, they quickly deactivate the hippocampus and activate caudate nucleus to successfully learn the probabilistic associations [6] , see Figure 1a . Conversely, overall, patients with schizophrenia appear to be incapable of sufficiently activating caudate nucleus ( Figure 1b ) and only those patients who are capable of activating an alternate neural network including the parahippocampal gyrus, rostral prefrontal, cingulate, and parietal cortices appear to be capable of successfully learning the probabilistic associations [24 ] , Figure 1c . It should be noted that the patients in this study were all receiving antipsychotic medication that blocks dopamine receptor binding primarily in the striatum; however, there was no relationship shown between mean daily chlorpromazine equivalent dose and probabilistic association learning acquisition rate in the patients with schizophrenia [24 ] . In similar fashion to patients with schizophrenia, patients with Parkinson's disease (who have abnormal input to the striatum) have also been shown to activate medial temporal lobe circuitry during probabilistic association learning [25] .
Brain stimulation using transcranial Direct Current Stimulation (tDCS) to the prefrontal cortex of patients with schizophrenia has elicited improvement in probabilistic association learning. Twenty minutes of anodal stimulation (which facilitates neural activity under the area of the electrode) to the dorsolateral prefrontal cortex of 20 patients with schizophrenia during task engagement produced significant improvement in probabilistic association learning in those 12 patients with schizophrenia who showed greater potential to learn the probabilistic cueoutcome associations at baseline (based on regression analyses showing differential significant effects of baseline on performance during active tDCS and sham conditions [26 ] ), Figure 1c (in which 'tDCS"' indicates putatively increased neuronal activity with administration of anodal tDCS) and Figure 2 [26 ] . Thus, anodal tDCS to the dorsolateral prefrontal cortex in patients with schizophrenia can facilitate access to neural reserves in the prefrontal cortex to enhance probabilistic association learning in patients who retain capacity (Figure 1c ) to learn at baseline. These studies provide the first Probabilistic association learning in schizophrenia Weickert 3 preliminary evidence of the abnormal neuronal activity in conjunction with probabilistic association learning impairment in schizophrenia. However, further evidence was needed to establish that these learning deficits are intrinsic to the illness.
Probabilistic association learning deficits are intrinsic to the illness
Since patients with schizophrenia in these studies were receiving antipsychotic medication, it was not clear whether the probabilistic association learning deficits reported were intrinsic factors related to the illness or whether these deficits were simply adverse effects of antipsychotic treatment. A number of studies have addressed the issue of treatment effects and, overall, they provide reliable support for the hypothesis that the probabilistic association learning deficits reported in schizophrenia are intrinsic to the illness. One relatively large study showed significant differences in the proportions of good versus poor learners of the probabilistic associations among 121 healthy participants, 108 patients with schizophrenia and 82 of their unaffected siblings (with the proportion of good learning unaffected siblings being intermediate between the patient and healthy control groups, yielding a moderate relative risk) [21] . Thus, unaffected siblings of patients with schizophrenia can share some of the genetic (and environmental) factors that may contribute to the development of schizophrenia; however, unlike the patients with schizophrenia, the unaffected siblings had not received a course of Three-way interaction among transcranial Direct Current Stimulation (tDCS) cluster (treatment responders versus treatment non-responders based on cluster analysis) trial block and condition (active versus sham). Vertical bars denote standard error. *P 0.05 based on Least Significant Difference tests comparing active versus sham conditions within each tDCS cluster of responders and non-responders. From [26 ] .
antipsychotic medication that may negatively influence frontal-striatal function and dopamine receptor binding/ signaling.
Another study showed that healthy, first degree relatives of patients with schizophrenia failed to automate probabilistic association learning to the same extent as a healthy comparison group and instead, the healthy relatives of patients relied on an alternate strategy of controlled (nonautomated) processing to attain normal performance [27] . Further, in a series of studies, healthy siblings of childhood onset schizophrenia patients (who are at high risk to develop schizophrenia) were shown to display impaired probabilistic association learning, reduced frontal-striatal brain activity during probabilistic association learning, and decreased superior frontal gyrus and increased cerebellum volumes in relation to poor probabilistic association learning [28,29 ,30] . These adolescent siblings of childhood onset patients with schizophrenia also had significantly reduced gray matter mean diffusivity (a diffusion tensor imaging marker of cellular damage) in the putamen and significantly reduced white matter tract mean diffusivity, radial diffusivity (a diffusion tensor imaging marker of decreased myelination) and axial diffusivity (a diffusion tensor imaging marker of axonal pruning) relative to controls and a significant positive correlation of probabilistic association learning with axial diffusivity in the corpus callosum in siblings of childhood onset schizophrenia patients [31] .
A relatively unique study [23 ] , in which patients with schizophrenia were withdrawn from their antipsychotic medication for 4 weeks, demonstrated two important aspects related to probabilistic association learning in schizophrenia (Figure 3) . First, while receiving antipsychotics, patients with schizophrenia failed to improve significantly above chance levels of performance during both early and late learning phases (Figure 3c) . Second, following antipsychotic medication withdrawal, patients with schizophrenia improved significantly above chance levels of performance only during the later phase of learning the probabilistic associations ( Figure 3b) ; demonstrating that the early phase of learning (reliably associated with caudate nucleus activity in healthy adults [6] [7] 24 ]) remained impaired as a consequence of the illness. Thus, patients off antipsychotics displayed early phase probabilistic association learning impairment and treatment with antipsychotics further supresses the later phase of probabilistic association learning in schizophrenia.
Probabilistic association learning in schizophrenia Weickert 5 Acquisition (learning) curves during probabilistic association learning in patients with schizophrenia (SC) on and off antipsychotics versus patients with Parkinson's disease (PD) on and off dopaminergic medication, healthy young controls (YC) and elderly controls (EC) showing significant improvement above chance levels of performance in different groups and conditions. From [23 In a study of healthy adults with high versus low schizotypal personality traits, those displaying a high degree of schizotypal personality traits displayed significantly worse probabilistic association learning performance relative to those with few schizotypal personality traits [32] . These findings were confirmed in an independent study showing that healthy adults with high perceptual aberration/magical ideation scores displayed significantly impaired probabilistic association learning [33] . Overall, these findings in unaffected siblings, first-degree relatives of patients with schizophrenia, patients with schizophrenia who were withdrawn from antipsychotic medication, and healthy adults displaying a high degree of schizotypal personality traits, all reliably demonstrate that probabilistic association learning deficits reported in patients with schizophrenia are an intrinsic component of the disease process and are not a mere artifact of antipsychotic treatment or years of unremitting illness. However, further evidence was needed to establish the molecular mechanisms underlying these striatal dependent, probabilistic association learning deficits in schizophrenia.
Molecular mechanisms of probabilistic association learning in schizophrenia
Recent studies have begun to assess the molecular mechanisms of probabilistic association learning deficits in schizophrenia. Brain Derived Neurotrophic Factor (BDNF) is a well-known growth factor that is important for promoting synaptic strength and modifying brain plasticity during learning [34] . An fMRI study found that while there were moderately strong, significant, positive relationships between peripheral BDNF levels and bilateral caudate and right parietal lobe activity in 25 healthy adults during probabilistic association learning ( Figure 1a in which 'BDNF"' represents a positive relationship between peripheral BDNF levels and neural activity during learning), there were no significant correlations between peripheral BDNF levels and dorsolateral prefrontal cortex, parietal cortex, or caudate activity in 17 patients with schizophrenia ( Figure 1b in which 'BDNF#' represents no relationship between peripheral BDNF levels and neural activity during learning) [35] . Additionally, in a study of 89 healthy young adults assessed for schizotypal personality traits and BDNF val66met genotype, BDNF met carriers displaying few schizotypal personality traits displayed the best performance while BDNF met carriers displaying a relatively high degree of schizotypal personality traits displayed the worst performance during probabilistic association learning [32] . Therefore, the BDNF val66met polymorphism influenced probabilistic association learning differently depending on the extent of schizotypal personality traits displayed.
Other molecules are also important for learning and memory. Estrogen receptor alpha (ESR-1) genetic polymorphism abnormalities have been associated with schizophrenia and ESR-alpha mRNA has been shown to be altered in the brains of people with schizophrenia [36] . Furthermore, estrogen is a known modulator of cognition and has been shown to improve memory in animal and human studies [37] . Additionally, the selective estrogen receptor modulator (SERM) raloxifene has been shown to preserve neural activity during memory performance in healthy older men [38] . In a randomized, double-blind, placebo controlled, cross-over adjunctive treatment trial administering 120 mg daily of the SERM raloxifene to 25 men and women with schizophrenia, raloxifene significantly improved probabilistic association learning and significantly increased parahippocampal/ hippocampal activity relative to the placebo condition (Figure 1c for a schematic representation in which 'SERM"' signifies increased neural activity with administration of the SERM raloxifene) [39 ] . Thus, the results from this clinical trial independently confirms earlier work demonstrating that those patients with schizophrenia who can learn the probabilistic associations use an alternate neural network that includes the hippocampal formation [24 ] and that estrogen modulation in the hippocampus can influence probabilistic association learning in men and women with schizophrenia.
Recent work has also shown that a substantial proportion of patients with schizophrenia (approximately 40%) display elevated inflammation markers based on elevated cytokine levels in peripheral blood and in post-mortem brain samples (from the prefrontal cortex) [40] [41] [42] . One study has shown moderately strong, inverse relationships of peripheral cytokine levels (i.e. Interleukin-1b) with both verbal fluency scores and Broca's area volume in schizophrenia [42] . Thus, future studies may provide further insight into the nature of the illness by testing the extent to which peripheral inflammatory markers (e.g. cytokines, C-reactive protein) are related to probabilistic association learning in patients with schizophrenia.
Conclusions
Overall, the results from these studies demonstrate that probabilistic association learning, representing normal frontal-striatal function in healthy adults, is often impaired in patients with schizophrenia and that this frontal-striatal dependent probabilistic association learning deficit is intrinsic to the illness and not an artifact of antipsychotic treatment or chronic illness. This deficit may be characteristic of general habit learning impairment related to overall striatal dysfunction in schizophrenia, but most evidence suggests that instead it represents a specific deficit dependent on the probabilistic nature of the associations and a gradual learning that is related to caudate nucleus dysfunction in schizophrenia. We are just beginning to understand the molecular mechanisms related to the probabilistic association learning deficit in patients with schizophrenia; thus, further studies are needed to provide support for these preliminary findings. There is early evidence for a role of neurotrophins (e.g. BDNF) and hormones (e.g. estrogen) in the molecular dysfunction and restoration of probabilistic association learning in schizophrenia. Future studies may also aim to focus on the role of inflammation in the manifestation of striatal dependent probabilistic association learning deficits in schizophrenia. Thus, by following this line of evidence based research, future studies may provide increasing evidence for the underexamined role of abnormal striatal activity in the pathophysiological mechanisms underlying the development of schizophrenia.
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